|
Volumn 508, Issue 7495, 2014, Pages 158-159
|
Metabolic quirks yield tumour hope
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 HYDROXYGLUTARIC ACID;
AG 221;
ANTINEOPLASTIC AGENT;
GLUCOSE;
ISOCITRATE DEHYDROGENASE 1;
ISOCITRATE DEHYDROGENASE 2;
PYRUVATE KINASE;
UNCLASSIFIED DRUG;
ALPHA-HYDROXYGLUTARATE;
GLUTARIC ACID DERIVATIVE;
IDH1 PROTEIN, HUMAN;
ISOCITRATE DEHYDROGENASE;
ISOCITRATE DEHYDROGENASE 2, HUMAN;
BIOCHEMISTRY;
BRAIN CANCER;
CANCER CELL;
CANCER PATIENT;
CANCER RESEARCH;
CITRIC ACID CYCLE;
CLINICAL TRIAL (TOPIC);
GENE MUTATION;
HUMAN;
LEUKEMIA;
MALIGNANT NEOPLASTIC DISEASE;
METABOLISM;
NOTE;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
ANIMAL;
DRUG ANTAGONISM;
ENZYMOLOGY;
GENETICS;
MOUSE;
NEOPLASM;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CITRIC ACID CYCLE;
CLINICAL TRIALS AS TOPIC;
GLUCOSE;
GLUTARATES;
HUMANS;
ISOCITRATE DEHYDROGENASE;
METABOLIC NETWORKS AND PATHWAYS;
MICE;
NEOPLASMS;
PYRUVATE KINASE;
|
EID: 84900345062
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/508158a Document Type: Note |
Times cited : (14)
|
References (0)
|